gabapentin
Generic: gabapentin
Labeler: bluepoint laboratoriesDrug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
bluepoint laboratories
Dosage Form
TABLET
Routes
Active Ingredients
gabapentin 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68001-412
Product ID
68001-412_3e4d1b97-0022-6671-e063-6294a90ae02d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077662
Listing Expiration
2026-12-31
Marketing Start
2019-09-30
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68001412
Hyphenated Format
68001-412
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA077662 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (68001-412-00)
- 500 TABLET in 1 BOTTLE (68001-412-03)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3e4d1b97-0022-6671-e063-6294a90ae02d", "openfda": {"nui": ["N0000008486"], "upc": ["0368001412001", "0368001411004"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["3368bf70-d466-4765-b2b7-7fe967a8c2b7"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68001-412-00)", "package_ndc": "68001-412-00", "marketing_start_date": "20190930"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (68001-412-03)", "package_ndc": "68001-412-03", "marketing_start_date": "20190930"}], "brand_name": "Gabapentin", "product_id": "68001-412_3e4d1b97-0022-6671-e063-6294a90ae02d", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68001-412", "generic_name": "Gabapentin", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA077662", "marketing_category": "ANDA", "marketing_start_date": "20190930", "listing_expiration_date": "20261231"}